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Cancer immunoediting is a dynamic process of crosstalk between tumor cells and the
immune system. Herein, we explore the fast zebrafish xenograft model to investigate the
innate immune contribution to this process. Using multiple breast and colorectal cancer cell
lines and zAvatars, we find that some are cleared (regressors) while others engraft (pro-
gressors) in zebrafish xenografts. We focus on two human colorectal cancer cells derived
from the same patient that show contrasting engraftment/clearance profiles. Using poly-
clonal xenografts to mimic intra-tumor heterogeneity, we demonstrate that SW620_pro-
gressors can block clearance of SW480_regressors. SW480_regressors recruit macrophages
and neutrophils more efficiently than SW620_progressors; SW620_progressors however,
modulate macrophages towards a pro-tumoral phenotype. Genetic and chemical suppression
of myeloid cells indicates that macrophages and neutrophils play a crucial role in clearance.
Single-cell-transcriptome analysis shows a fast subclonal selection, with clearance of
regressor subclones associated with IFN/Notch signaling and escaper-expanded subclones
with enrichment of IL10 pathway. Overall, our work opens the possibility of using zebrafish
xenografts as living biomarkers of the tumor microenvironment.
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C linically detectable tumors represent the ultimate con-sequence of tumor immunoediting, which includes thedetection and clearance of the majority of the immuno-
genic clones by the immune system1. Clones that escape immune
detection further hijack immune cells to support tumorigenesis2.
Although the concept of immunoediting is well established, the
role of innate immune cells in shaping and selecting subclones, as
well as the mechanisms that allow for innate immune evasion
remain less explored3.
In recent years, there has been a major effort to uncover the role
of adaptive immunity on tumor immune surveillance/evasion/
suppression, which has been translated into promising new
immunotherapies4. Immune checkpoint therapies aim to remove
inhibitory pathways that block anti-tumor T-cell responses in the
tumor microenvironment (TME). However, therapy may fail
because tumor cells do not express sufficient neo-antigens (not
immunogenic enough)5. Another major obstacle may be the pre-
sence of a suppressive (cold) TME composed of stroma and a
variety of immune cells, such as regulatory T cells (Treg), myeloid-
derived suppressor cells (MDSC), alternative activated pro-tumoral
macrophages (“M2-like”), and neutrophils (“N2-like”), that may
block anti-tumor immune responses5,6. In fact, innate myeloid-
derived cells effectively represent the major component of the TME
in most solid tumors5,7, often outweighing lymphocytes or even the
tumor cells themselves. These populations of the immune system
are present in all tissues. However, their role in cancer-induced
immune suppression and immunotherapy remains less explored
and understood. Increasing evidence supports a crucial anti- and
pro-tumorigenic role for innate immune cells4. Importantly, innate
pro-tumorigenic states are highly dynamic and can be selectively
reverted8, creating the possibility for new and more effective ther-
apeutic approaches.
The zebrafish model has emerged as a powerful tool to study
tumor biology and interactions with the immune system9–12.
Zebrafish have a highly conserved vertebrate innate immune
system, including complement, Toll-like receptors, neutrophils,
and macrophages capable of phagocytic activity. Another
advantage is that the full maturation of adaptive immunity only
occurs at 2–3 weeks post-fertilization13,14. This offers a time
window to study exclusively innate immune response in vivo,
independent of the adaptive system. In addition, transparency
allows for unprecedented real-time imaging of cell–cell interac-
tions and genetic tractability enables the engineering of reporter
lines and mutants14.
Recently, we have optimized zebrafish patient-derived xeno-
grafts (zPDXs)—“zAvatars” for personalized medicine15. The
assay is based on the injection of labeled tumor cells into zeb-
rafish embryos for assessment of tumor behavior and response to
therapy in just 4 days. Although only innate immunity is active,
we observed some heterogeneity in tumor engraftment. Here we
hypothesize that the zebrafish innate immune system can be
modulated by the tumor; itself capable of generating an immu-
nosuppressive TME or subjected to elimination. In the present
study, we apply a combination of zebrafish mono- and polyclonal
xenografts, “zAvatars”, zebrafish mutants and transgenics, mouse
xenografts, re-transplantation experiments, and single-cell tran-
scriptomics to test this hypothesis. We focus on a pair of human
colorectal cancer (CRC) cells derived from the same patient at
different stages of tumor progression: SW480 was derived from
the primary tumor, and SW620 from a lymph node metastasis
isolated 6 months later. SW480_regressors engraft poorly and
most tumors are cleared during the 4 days of the assay, whereas
SW620_progressors engraft very efficiently. Mixing SW480_re-
gressors with SW620_progressors in polyclonal tumors reduces
clearance of SW480_regressors, suggesting that progressors can
induce an immune suppressive environment. Indeed, not only
SW620 progressor tumors recruit less neutrophils and macro-
phages to the TME, but also polarize macrophages toward a M2-
like pro-tumoral phenotype. In addition, MIX polyclonal tumors
show an immune profile similar to the progressor tumors, i.e.,
reduced numbers of innate cells and “M2-like” polarization.
Genetic and chemical depletion of myeloid cells confirms that
macrophages and neutrophils play a crucial role in this clearance
process. To test whether innate immunoediting is occurring in
this short time frame, we perform re-transplantation experiments
of SW480 escaper tumors and show that these tumors engraft
more efficiently and generate bigger tumors with reduced mac-
rophage infiltration. Finally, single-cell RNA-seq reveals the
in vivo clearance and expansion of specific subclones.
Results
Zebrafish xenografts display differential engraftment profiles.
Using a zebrafish xenograft model15, we investigated the
engraftment efficiency of multiple human breast and CRC cell
lines. At 4 days post injection (4 dpi), we found that different
cancer cell lines display distinct engraftment profiles in zebrafish
xenografts. Of note, we describe engraftment as the frequency of
xenografts that present a tumor (at least 30 tumor cells) at 4 dpi
(Fig. 1a) and clearance as engraftment inhibition. We observed
that some cancer cell lines present a high engraftment rate—
above 80%, while others engraft poorly with an average engraft-
ment rate of ~20–30%. We define here these tumors as pro-
gressors and regressors, respectively, following Schreiber
nomenclature16 (Fig. 1a).
Strikingly, we observed differences in engraftment profiles
between cancer cells derived from the same patient at different
stages of tumor progression. While SW480 cells derived from the
primary tumor present a regressor behavior, SW620 cells isolated
from a lymph node metastasis 6 months later17,18 show a
progressor phenotype (Fig. 1a). These differences in engraftment
rates between both tumor cells were also originally reported in
mouse xenografts18.
Importantly, engraftment/clearance capacity did not seem to
correlate to proliferation potential or basal cell death. This is
exemplified by the breast cancer cells Hs578T_progressors, which
display a high engraftment rate (~95% engraftment), despite their
low proliferation and high level of apoptosis in comparison, for
instance, with breast cancer MDA-MB-468, which display lower
engraftment but are more proliferative and less apoptotic
(Supplementary Fig. 1a–d). Also, although SW620_progressors
are highly proliferative compared with SW480_regressors,
SW620_progressors present higher levels of apoptosis (Supplemen-
tary Fig. 1e–h).
Moreover, paradoxically, we observed that SW480_regressors
upon chemo- (FOLFOX-FO) or radiotherapy (RAD), may
increase their engraftment rate, and this can also be observed in
patient-derived xenografts (zAvatars) (Fig. 1b). Given the fact
that chemo/radiotherapy may elicit an immunosuppressive effect,
we hypothesized that this could reduce the zebrafish host anti-
tumor response, originally responsible for the regressor (clear-
ance) behavior.
Transcriptomic analysis between SW480 and SW620 xeno-
grafts. We next performed a general comparative transcriptomic
analysis between SW480_regressors and SW620_progressors. We
sought to focus on the SW480/SW620 pair of cell lines since they
derived from the same patient and therefore illustrate intra-
patient heterogeneity and eventually the original immunoediting
process from primary to metastasis progression. To this end,
SW480 and SW620 tumors were dissected from zebrafish xeno-
grafts at 2 dpi, a timepoint that corresponds to the timing when
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clearance is actively taking place (Supplementary Fig. 2). A pool
of ~30 tumors from at least three independent experiments was
collected for RNA extraction (Fig. 1c). The remaining xenografts
from the same experiments were followed until 4 dpi to deter-
mine final engraftment rates. We only used RNA samples from
experiments where SW480 engraftment was lower than ~30% and
SW620 engraftment was higher than 90%.
A differential expression analysis revealed 459 differentially
expressed genes (DEGs) between the two types of xenografts
(Fig. 1d, Supplementary Data 1). A gene set enrichment analysis
Fig. 1 Human cancer cells display differential engraftment profiles in zebrafish. a Engraftment is the ratio between the number of zebrafish xenografts
that maintain a tumor at 4 days post injection (dpi) and the number of total xenografts that were originally successful injected and survived until day 4.
MDA-MB-231 (MDA-231), MDA-MB-468 (MDA-468), and Hs578T are breast cancer cell lines. SW480, SW48, HT29, SW620, HCT116, and Hke3 are
colorectal (CRC) cancer cell lines. Tumor cells were labeled and injected into the perivitelline space (PVS) of 2 days post-fertilization (dpf) zebrafish
embryos. Each dot represents one independent experiment, number of independent experiments: 19 SW480, 3 SW48, 5 MDA-231 12 MDA-468, 5 HT29,
7 Hs578T, 22 SW620, 6 HCT116, 7 Hke3. Total number of xenografts analyzed (N) is depicted in the charts. Error bars indicate mean ± S.D. b Engraftment
of SW480 and zebrafish patient-derived xenografts (zPDX-zAvatars) at 4 dpi, treated with FOLFOX (FO) and radiotherapy (RAD) and their respective
controls. Each dot represents one independent experiment (3 SW480, 1 zPDX). Total number of xenografts analyzed (N) is depicted in the charts. Error
bars indicate mean ± S.D. See also Supplementary Fig. 1. c–f Comparative transcriptomic analysis between SW480 and SW620 xenografts. c Schematic
representation of the experiment where SW480 (in red) and SW620 (in green) tumors were dissected at 2 dpi for RNA extraction (~30 tumors of each
condition). d Heatmap presents a two-dimensional dendogram (based on Pearson’s correlation coefficient distance) of log2 counts-per-million (logCPM),
normalized expression values of differentially expressed genes (N= 459, cut-off of FDR < 0.05 and absolute log2FC > 1) in SW480 (low engraftment)
versus SW620 (high engraftment) comparison, where colors represent expression values scaled by row (Z-scores). e, f GSEA of SW480 and SW620
xenografts. Source data are provided as a Source data file.
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(GSEA)19 revealed an enrichment mainly in three biological
processes: immune response, metabolism and signaling (Fig. 1e, f).
Whereas genes involved in epithelial to mesenchymal transition
(EMT) were specifically enriched in SW480 xenografts, genes
involved in proliferation and hypoxia/angiogenesis were specifi-
cally represented in SW620 tumors (Fig. 1e, f). The enrichment
analysis is in accordance with our earlier results, where
SW480 showed an increased metastatic potential and SW620 an
increased capacity to recruit blood vessels15. We also identified
several immune-related pathways in SW480 enriched DEGs, in
particular those involved in graft-versus-host disease,
IL6 signaling, and allograft rejection pathways. In contrast,
SW620 DEGs were characterized by an enrichment in IFN and
TNF signaling, ROS and NOTCH pathways (Jagged1, MAML2),
but not in graft-versus-host disease or allograft rejection pathways
(Fig. 1e, f). These results suggest that SW480 tumors express
signals that may stimulate clearance, while SW620 tumors have
reduced activity of rejection-related pathways.
Progressors are able to protect regressors from being cleared.
In order to test if progressors were able to induce a suppressive
environment, and thus avoid clearance of regressors,
SW620_progressors were mixed with SW480_regressors, thereby
generating polyclonal xenografts in vivo. To distinguish the two
cell lines, SW480 cells were labeled with red CM-DiI-dye and
SW620 with green CMFDA-dye and mixed in a 1:1 proportion
(Fig. 2a, b). The three conditions were tested in parallel—SW480
(red) alone, SW620 (green) alone, and MIX (SW480+ SW620)
and engraftment quantified at 4 dpi. As expected, SW480 cells
presented a low average engraftment rate of ~20%, with the
majority of tumors being cleared from the zebrafish host; whereas
SW620 had an average engraftment rate of ~90%. However, when
mixed, engraftment of SW480 increased to more than double, to
~60% (P < 0.0001). In contrast, engraftment of SW620 decreased
~35% (P < 0.0001) in relation to when it is alone (Fig. 2c). Ana-
lysis of the relative proportions of each clone in each MIX
xenograft, by confocal microscopy, showed that both populations
were always present, with SW620 behaving as the dominant
clone, making up ~70% of the tumor (Fig. 2d). Interestingly,
when we compared the size of each population (number of cells)
we found that the number of SW480 cells increased in polyclonal
xenografts, i.e., SW480 benefits from the proximity of SW620
cells, suggesting that SW620 cells can protect SW480 cells from
clearance and possibly provide some survival cues (Fig. 2e).
Next, we engrafted a mixture of SW480_regressor with another
CRC progressor cell line derived from a different patient—
HCT116 (Fig. 2f, g). In this instance, in the presence of HCT116,
the engraftment rate of SW480 was further increased, from ~20 to
90% (P < 0.0001) (Fig. 2h), while analysis of each xenograft
revealed SW480:HCT116 frequencies of 30:70% (Fig. 2i). Once
again, the size of SW480 tumors increased in the presence of a
progressor tumor cell (Fig. 2j).
These results suggest that “regressors” can indeed lose their
“regression” profile in the presence of “progressors” and that the
latter might generate a protective immunosuppressive micro-
environment. These results are in accordance with mouse
xenograft studies, which show that advanced metastatic tumors
engraft more efficiently and are more immunosuppressive than
primary tumors20,21.
SW480 regressor TME is enriched in innate immune cells. To
evaluate if regressors and progressors are able to generate dif-
ferent tumor ecosystems, we analyzed the presence of neutrophils
and macrophages in the tumors, the main innate immune cells
present at this stage of development (2–6 days post fertilization-
dpf)14,22. To this end, we injected SW480, SW620, and MIX
tumor cells into Tg(mpx:eGFP)23 and Tg(mpeg1:mcherry-F)24
zebrafish hosts, which have neutrophils (Fig. 3a, b) and macro-
phages (Fig. 3e, f) labeled, respectively.
As early as 24 hpi (1 dpi), we could detect a significant higher
recruitment of neutrophils and macrophages to the SW480
tumors in comparison to SW620 (neutrophils P < 0.0001,
macrophages P= 0.0011), a difference that was maintained and
reinforced at 4 dpi (neutrophils P < 0.0001, macrophages P=
0.0089) (Fig. 3c, d, g, h). Interestingly, MIX tumors showed a
TME similar to SW620, with significant lower recruitment of
neutrophils and macrophages than SW480 tumors (Fig. 3, SW480
vs MIX neutrophils P4dpi < 0.0001, macrophages P4dpi= 0.0025).
These results suggest that the presence of SW620 in the MIX is
able to block the recruitment of immune cells toward the tumor.
We next questioned whether immune cell recruitment was
associated with the total number of tumor cells within the
tumoral mass. Linear regression analysis of the tumor size vs
immune cell counts suggests a weak correlation between tumor
size and immune cell infiltrates in SW480 tumors, but moderate
in SW620 tumors (Supplementary Fig. 3).
SW480 and SW620 tumors modulate zebrafish macrophage
polarization. In the TME, tumor-associated macrophages
(TAMs) and neutrophils (TANs) can either adopt an anti-(M1/
N1-like) or pro-tumoral (M2/N2-like) phenotype, known to be
modulated by multiple tumor-derived signals24,25. To investigate
the polarization state of macrophages in both TMEs, SW480, and
SW620 cells were injected into double transgenic animals Tg
(mpeg1:mCherry-F; tnfa:eGFP-F)24 and each population was
analyzed at 1 and 4 dpi (Fig. 4a, b and Supplementary Fig. 4a, b).
Quantification of the immune cell populations showed that
SW480_regressors are able to recruit a significantly higher
number of inflammatory cells (TNFa positive cells and M1-like
TNFa+mpeg+), than SW620_progressors, since 1 dpi (Supple-
mentary Fig. 4a, b, M1-like P1dpi= 0.0003; P4dpi= 0.001).
Moreover, when we analyzed the proportions of M1-like (TNFa+)
versus M2-like (TNFa−) macrophages, we observed that the
SW480 TME presented ~57% M1-like to 43% M2-like- macro-
phages at 4 dpi (Fig. 4c, d). In clear contrast, the TME of
SW620_progressors cells presented a ratio of ~35% M1-like to
~65% M2-like macrophages (Fig. 4c). Interestingly, a progressive
increase in M2-like-(TNFa−) macrophages in the TME of SW620
from 1 to 4 dpi was observed (Fig. 4c). This result suggests that
SW620_progressor cells can polarize macrophages to a M2-like
pro-tumoral state. In addition, the MIX xenografts again show
similar dynamics to SW620 xenografts (M2- >M1-like macro-
phages), from 1 to 4 dpi (Fig. 4c, d).
Moreover, as expected, we detected a higher phagocytic activity
(displayed by M1-like TNFa+/mpeg+ and TNFa+/mpeg− cells)
in SW480 TME than in SW620 (Supplementary Fig. 4c–i,
P < 0.0001). In summary, these results show that human tumor
cells are able to modulate the zebrafish TME toward a more anti-
or pro-tumoral state, through macrophage polarization and
consequent phagocytic properties.
Engraftment of MIX tumors correlates with SW620 ratio. Next,
we questioned whether clonal proportions could affect tumor
engraftment and TME modulation. Zebrafish embryos were
injected with mixtures of regressors with progressors at different
ratios (1:3, 1:1, and 3:1) (Supplementary Fig. 5a). We found that a
proportional increase in the number of SW620_progressors cells
in polyclonal tumors correlates with higher engraftment rates
(Supplementary Fig. 5b, c, R2= 0.78, P < 0.0001). Interestingly,
instead of a steady reduction of the immune infiltrate into the
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Fig. 2 Progressor tumor cells are able to protect regressors from being cleared. Tumor cells were labeled with lipophilic dyes and injected into the PVS of
2dpf zebrafish embryos. a, b Representative images of SW480 (in red), SW620 (in green), and MIX (1:1) polyclonal zebrafish xenografts at 4 dpi.
a Fluorescence stereoscope images. b Confocal images. c Engraftment quantification at 4 dpi (Fisher exact test ****P < 0.0001). Graph shows the mean ± S.
D. Each dot represents one independent experiments (5), and each set of independent experiments is represented in a different gray color.
d Representative quantification of the proportions of each clone within each xenograft (N= 10) from four independent experiment. e Quantification of
tumor size (no. of tumor cells) at 4 dpi (unpaired two-sided Mann–Whitney test ****P < 0.0001). Graph shows the mean ± SEM from four independent
experiments, each dot represents one xenograft. f, g Representative images of SW480 (in red), HCT116 (in green), and MIX (1:1) zebrafish xenografts at 4
dpi. f Fluorescence stereoscope images. g Confocal images. h Engraftment quantification at 4 dpi (Fisher exact test ****P < 0.0001, ***P= 0.0005). Graph
shows the mean ± S.D. Each dot represents one independent experiment (N= 3), and each set of independent experiments is in a different gray color.
i Representative quantification of the cell proportions of each clone within each xenograft (N= 10) from one independent experiment. j Quantification of
tumor size (no. of tumor cells) at 4 dpi (unpaired two-sided Mann–Whitney test **P= 0.0012, Cohen’s D g= 4.88; ***P= 0.0002, Cohen’s D g= 4.32).
Graph shows the mean ± SEM from one independent experiment, each dot represents one xenograft. Scale bars: 50 μm. Dashed lines encircle tumor areas.
Nuclei are stained with DAPI (blue). N is depicted in the charts. Source data are provided as a Source data file.
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polyclonal tumors, the presence of SW620, even in a 3:1 ratio
(SW480:SW620), was sufficient to block neutrophil recruitment
(P= 0.0066) (Supplementary Fig. 5d). However, macrophage
recruitment is only reduced when SW620 increases up to 50% of
tumor cells (Supplementary Fig. 5e), suggesting that neutrophil
and macrophage recruitment have different dynamics, possibly
modulated by different mechanisms.
Zebrafish innate immune cells regulate SW480 clearance. The
above results show that SW620_progressors protect SW480_re-
gressors from being cleared and that SW480 cells are able to
recruit more efficiently innate immune cells. Moreover, increas-
ing amounts of SW620 in MIX xenografts correlate with
increased engraftment of SW480 and the presence of
SW620 seems sufficient to reduce immune cell infiltration. All
Fig. 3 SW480_regressor TME is enriched in innate immune cells. a, b Representative confocal projection images of neutrophils in SW480,
SW620, and MIX tumors from Tg(mpx:eGFP) zebrafish xenografts at 4 dpi. c, d Quantification of neutrophils percentage (no. of neutrophils/no. of tumor
cells x 100) within SW480, SW620, and MIX TME, at 1 dpi (c, ****P < 0.0001, ***P= 0.0002, **P= 0.0094) and 4 dpi (d, ****P < 0.0001, ns= 0.39).
e, f Representative confocal projection images of macrophages in SW480, SW620, and MIX tumors from Tg(mpeg1:mcherry-F) zebrafish xenografts at 4 dpi.
g, h Quantification of macrophage percentage (no. of macrophages/no. of tumor cells x 100) within SW480, SW620, and MIX tumors, at 1 dpi (g, ***P=
0.0009, **P= 0.0011, ns= 0.45) and 4 dpi (h, 480 vs 620 **P= 0.0089, 480 vs MIX **P= 0.0025, *P= 0.024). SW480 (red) and SW620 (green),
neutrophils (white) and macrophages (white) fake colors. Scale bars: 50 μm. Dashed lines encircle tumor areas. Nuclei are stained with DAPI. N is depicted
in the chart. Each dot represents one xenograft. Error bars indicate mean ± SEM (from three independent experiments). All data were analyzed using
unpaired two-sided Mann–Whitney test. See also Supplementary Fig. 3. Source data are provided as a Source data file.
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together, these results suggest that innate immunity plays an
active role in clearance/engraftment.
To directly test this, we injected both CRC cell lines into
mutant zebrafish embryos that have either a transient down-
regulation of neutrophils (runx1w84x mutant)26 or of macro-
phages (M-CFS receptor/fms mutant csf1raj4blue panther)27
(Fig. 5a–b). The results show that runx1w84x and panther mutants
present a significant increase in the engraftment of SW480
regressors cells (Fig. 5c). In runx1w84x mutants, we observed a
significant 3.2-fold increase of engraftment (P < 0.0001), whereas
in panther mutants we observed a 2.8-fold of increase
(P < 0.0001) (Fig. 5c). In contrast, downregulation of neutrophils
or macrophages had no significant impact on SW620_progres-
sors’ engraftment rate. Interestingly, quantification of tumor size
in each background shows that SW480 regressors increase their
size in panther mutants, which have reduced number of
macrophages (Fig. 5d, P= 0.0013).
Overall, our results suggest that both myeloid cells play a
crucial role in the SW480_regressors’ clearance and that
SW620_progressors are able to evade and/or suppress the host
innate immune system.
Resident and definitive macrophages are required for SW480
clearance. Recent studies have shown differential functions for
resident macrophages and hematopoietic monocyte-derived
macrophages in tumorigenesis28–30. In 3 dpf zebrafish larvae,
macrophages are distributed in several peripheral tissues, such as
the brain, heart, retina, and muscle, and in the caudal hemato-
poietic tissue (CHT), a transient hematopoietic tissue9. In panther
mutants (csf1raj4blue), it has been shown that there is an overall
~40% reduction of the macrophage population and impairment
of their migration. However, the tissue-resident macrophages
(derived from the primitive and transient waves of hematopoiesis)
show a stronger reduction (~60%) than macrophages derived from
the second-monocytic definitive wave (CHT-20%)31–33. The results
observed in panther mutants thus reflect mostly the contribution of
the resident macrophages32. To further investigate the role of the
different macrophages in tumor clearance, we depleted most mac-
rophage population by using Liposome-Clodronate (L-clodronate),
which targets macrophages regardless of their embryonic origin.
Strikingly, upon almost complete macrophage depletion (without
affecting neutrophil numbers32, see Fig. 5e–g and Supplementary
Fig. 6a, b), SW480 engraftment reaches almost 100% (Fig. 5k, P <
0.0001), contrasting with the significant but less pronounced
engraftment increase in panthermutants (~60%, Fig. 5c). Moreover,
quantification of the tumor size also shows that SW480 tumor size
increases by almost 2-fold (Fig. 5h–j, l, L-PBS vs L-Clodro, P=
0.02). In summary, our results highlight a major role for both
tissue-resident and peripheral macrophages in tumor clearance.
Conservation of phenotypes in mouse xenografts. Zebrafish has
become a relevant animal model to study cancer. This is only
possible due to the major conservation of genes and signaling
pathways between human and zebrafish9,13. Nevertheless, as
mouse is the gold-standard model in cancer and immunology, we
tested if the phenotypes unveiled in zebrafish were conserved
across species. SW480, SW620, and MIX mouse xenografts were
generated using as host the immunocompromised mice strain
Rag1−/− C57BL6/N, lacking mature B and T cells34.
However, in contrast with previous mouse xenografts18 and
our zebrafish studies using SW480 and SW620 cells, we could not
detect major differences in engraftment capacity between SW480
and SW620. This discrepancy between our mouse experiments
with zebrafish engraftment and the previous published mouse
studies may be a reflection of our use of different mutations and
background strains, both of which were immunodeficient but
with different immunological repertoires. Instead of using mouse
Rag1−/− C57BL6/N, Hewitt et al.18, used BalbC nude (Foxn1
mutation) mice, which lack a thymus and functional B cells,
whereas Rag1−/− mutants lack mature B and T cells34.
Nevertheless, analysis of the F4/80+CD80+macrophages, showed
that SW480 tumors were more enriched in “M1-like” anti-tumoral
Fig. 4 SW480 and SW620 human tumor cells modulate zebrafish macrophage polarization. a, b Representative confocal images of SW480, SW620,
and MIX xenografts injected in Tg(mpeg1:mcherry-F, tnfa:GFP-F) at 1 and 4 dpi. Red: macrophages; green: TNFa+ cells; yellow: overlay of macrophages in red
and TNFa+ cells in green—M1-like macrophages. c Proportion of M1- and M2-like macrophages in the TME at 1 and 4 dpi (paired two-sided t test, **P=
0.0033, ns= 0.1833, ns= 0.1160, ****P < 0.0001, *P= 0.0116, ****P < 0.0001). d Quantification of absolute numbers of M1- and M2-like macrophages in
the TME at 1 and 4 dpi (paired two-sided Wilcoxon rank test **P= 0.0016, ns= 0.3086, ns= 0.1473, ***P < 0.0002, *P= 0.0205, ***P < 0.0005). Scale
bars: 50 μm. Dashed lines encircle tumor areas. N is depicted in the images. In c and d, the number of xenografts analyzed is: SW480_1 dpi N= 21,
SW480_4 dpi N= 11, SW620_1 dpi N= 31, SW620_4 dpi N= 31, MIX_1 dpi N= 12, and MIX_4 dpi N= 12. Images are maximum intensity projections. Each
dot represents one xenograft. Error bars indicate mean ± SEM (from 2 independent experiments in SW480, 3 in SW620, and 1 experiment for the MIX).
Source data are provided as a Source data file.
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macrophage population than SW620 or in MIX (Fig. 6a–c, d, P=
0.016, see Supplementary Fig. 7 for gating strategy). Also, like our
previous zebrafish results, SW620 cells became the dominant clone
in MIX mouse xenografts (Fig. 6e, *P= 0.029).
To test whether mouse macrophages can actively modulate
SW480 tumors, macrophages were depleted with L-clodronate.
Results show that similarly to zebrafish, macrophage depletion
leads to an increase in tumor size (Fig. 6f, **P= 0.007,
Fig. 5 Zebrafish innate immune cells regulate clearance of SW480 tumor cells. a, b Representative confocal images of SW480 and SW620 xenografts in
runx1w84x and csf1raj4blue (panther) mutants. SW480 were labeled in red and SW620 in green. c Quantification of engraftment in runx1w84x and csf1raj4blue
(panther) mutants and respective controls (Fisher exact test, ****P < 0.0001, SW620 wt vs SW620 runx1w84x ns= 0.62, SW620 wt vs SW620 panther
ns= 0.09). Error bars represent mean ± S.D. Each dot represents one independent experiment. d Quantification of tumor size in runx1w84x and csf1raj4blue
(panther) mutants and respective controls (unpaired two-sided Mann–Whitney test—SW480 wt vs SW480 runx1w84x ns= 0.22, **P= 0.0013, SW620 wt
vs SW620 runx1w84x ns= 0.44, SW620 wt vs SW620 panther ns= 0.18). Error bars represent mean ± SEM, each dot represents one xenograft from
3 independent experiments. e–j Zebrafish embryos with 2 dpf were injected simultaneously with SW480 tumor cells (in green) with PBS (control), with
L-PBS or with L-Clodronate liposomes into Tg(mpeg1:mcherry) background (macrophages in red). e–g Representative fluorescence stereoscope images of
SW480 xenografts at 1 dpi in the different conditions. h–j Representative confocal images of SW480 xenografts at 4 dpi. k Quantification of engraftment: Fisher
exact test ns=0.83, ****P < 0.0001; error bars represent mean ± S.D.; each dot represents one independent experiment, and each set of independent experiment
is represented in a different gray color. l Quantification of tumor size—no. of tumor cells (unpaired two-sided Mann–Whitney test ns=0.062, ****P < 0.0001,
*P=0.022, error bars represent mean ± SEM) in the different experimental conditions at 4 dpi, each dot represents one xenograft from 3 independent
experiments. Scale bars: 50 μm. White dashed lines encircle tumor areas. Nuclei are stained with DAPI. N is depicted in the chart. See also Supplementary Fig. 6.
Source data are provided as a Source data file.
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*P= 0.017), suggesting that the role of macrophages in SW480
TME is conserved across species.
As a comment on the differences of the models, the analysis of
the murine model was performed ~24 days post tumor injection,
while our zebrafish TME analysis was performed at 1 and 4 dpi,
i.e., a discrepancy of ~20 days. We believe that the zebrafish
model allows for an immediate snapshot of the “tumor state”, but
the murine model allows to study how these tumor-TME
interactions evolve along time. Therefore, this “timing” issue
can account for some differences, and does not necessarily
undermine one model or the other.
Innate immunoediting in zebrafish xenografts. Next, we aimed
at analyzing if engrafted zebrafish SW480 tumors were under-
going innate immunoediting, and therefore, would be able to
escape host innate immunity.
To this end, seven SW480 tumors were dissected at 4 dpi, from
an experiment that yielded ~12% engraftment. Dissected tumors
were then expanded in vitro for three passages (Fig. 7a) and these
(SW480zEscapers cells) were next injected into 2 dpf zebrafish
embryos. Engraftment, tumor size, proliferation, apoptosis, and
macrophage infiltration were quantified and compared to
parental cells. Strikingly, SW480zEscapers engrafted much more
efficiently (from an average of ~20% in parental to ~60% in
SW480zEscapers, P < 0.0001) (Fig. 7b, c) and tumor size
increased in relation to parental tumors (Fig. 7d, P < 0.0001).
Interestingly, we could not detect a higher proliferation rate in
these tumors (Fig. 7e) and apoptosis levels were slightly increased
(Fig. 7f). Thus, these results reinforce the idea that proliferation
and apoptosis are not the main drivers of engraftment/clearance.
Importantly, the macrophage infiltrate was significantly reduced
in these tumors (Fig. 7g, <0.0001). These results suggest that
innate immunity plays a critical role in immunoediting cancer
cells toward tumorigenesis.
Clearance and expansion of different SW480 subclones. To
investigate the molecular alterations that might underlie the
emergence of SW480 escapers (as well as the subclones that get
cleared), we performed single-cell transcriptomic profiling. We
injected SW480 parental cells (GFP transfected) and then dis-
sected tumors at 2 time-points for single-cell RNA-seq (scRNA-
seq): 1 dpi (where all subclones should be present) and at 4 dpi
(where only the subclones that escape clearance are present)
(Fig. 8a). Dissociated single cells were sorted by fluorescence-
activated cell sorting (FACS) into 384-well plates for scRNAseq
SORT-seq35: 3 plates for the first timepoint and 2 plates for the
second (Fig. 8a, b and see Supplementary Fig. 8a for quality
control). Cells were pooled and clustered according to their gene
expression profiles using Seurat36, resulting in six different cell
clusters (cell states), which were visualized using the uniform
manifold approximation and projection (UMAP) approach37
(Fig. 8b, c, see Supplementary Fig. 8 for PCA and heatmap
showing the differential gene expression between different
clusters).
Comparing the clusters’ frequency between 1 and 4 days, it was
possible to follow how the various tumor clusters changed (Fig. 8)
but also the dynamics of the signaling pathways (Supplementary
Fig. 8d). Interestingly, two cell clusters (1 and 4) almost disappear
in just 3 days, whereas others maintain their frequency (0 and 2)
but others clearly expand (3 and 5). These results suggest that
some clusters were cleared (1 and 4), while others were able to
evade innate immune detection and were therefore maintained
(0, 2, 3, and 5) (Fig. 8e).
In cluster 1, whose frequency was strikingly reduced, enrich-
ment pathway analysis showed the activation of innate immune-
related pathways as the interferon pathway (Myd88 independent
TLR cascade and DNA-dependent activation of IFN-regulatory
factors) as well as several inflammatory cytokines (e.g., CX3CL1,
CXCL1) (Fig. 8d, e Supplementary Fig. 9a-c, Supplementary
Data 2). These cytokines are known to act as chemoattractants for
Fig. 6 Mice xenografts display similar TME behavior as zebrafish. a–c Representative graphs of flow cytometry analysis of the TME of SW480, SW620,
and MIX mouse (Rag1−/−C57BL/6J) xenografts at 3 weeks post inoculation. d Quantification of double positive F4/80, CD80 macrophage in each TME,
SW620 vs SW480. *P= 0.016, Cohen’s D g= 6.2; SW620 vs MIX ns= 0.29, Cohen’s D g= 0.83; SW480 vs MIX *P= 0.029, Cohen’s D g= 1.28).
e Quantification of the percentage of each clone in MIX mice xenografts, *P= 0.029, Cohen’s D g= 7.68. d, e Data from quantification of flow cytometry
analysis. Error bars represent mean ± S.D. f Growth curves of SW480 tumors treated with PBS, L-PBS, or L-Clodronate mice (f ns= 0.43, Cohen’s D g=
0.12, **P= 0.007, Cohen’s D g= 2.16, *P= 0.017, Cohen’s D g= 1.92). Error bars represent mean ± SEM. All data were analyzed using unpaired two-sided
Mann–Whitney test. To avoid macrophage repopulation, mice were injected every 4 days (see “Methods”). N is depicted in the chart. Each dot represents
one mouse xenograft. Source data are provided as a Source data file.
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various immune cells; the large CX3CL1/fractalkine attracting
T cells and monocytes38, whereas the small chemokine CXCL1
acts in particular to attract neutrophils during inflammation39.
Their increased expression in subclones that decrease frequency
in the tumor might contribute to this clearance.
In contrast, an enrichment of IL10 immunosuppressive related
signaling was observed in cluster 3 (which is expanded at 4 dpi),
suggesting that IL10 signaling might protect SW480_zEscapers
from clearance (Fig. 8d, e and Supplementary Fig. 9d).
Comparison analysis between expanding cluster 3 vs cleared
clusters (1 and 4) reveals the opposing dynamics between
IL10 signaling and IFNγ (Supplementary Fig. 9e).
SW480 and SW620 cells have been previously ascribed to a
stem-like subtype, with high expression of Wnt signaling targets
as well as other stem cell and mesenchymal genes, together with
low expression of differentiation markers40. As expected, we
could identify enrichment of Wnt and Notch pathways
(Supplementary Fig. 10), as these are major players in the
maintenance of the stem cell state and the regulation of
differentiation of transit-amplifying (TA) progenitors41.
Wnt signaling seemed to be highly active in cluster 3, as
highlighted by the higher expression of various pathway
components (NOTUM, APCDD1, and AXIN2, see Supplementary
Fig. 10a and Fig. 8e). In contrast, Notch activation was uniquely
predominant in cluster 1, as evidenced by the high expression of
HES1, HES5, and HEY2/L genes (Supplementary Fig. 10b), which
are canonical downstream targets and effectors of the pathway42.
Notch signaling, besides contributing to the stem cell state, is
essential in the decision between absorptive TA progenitors
(NOTCH_ON) vs secretory TA progenitors (NOTCH_OFF)41.
Since NOTCH-ON cluster 1 was mostly cleared, we wondered if
the other expanding clones had markers for the “opposing”
secretory-like fate. Indeed, we observed that expression of ASCL-2,
TFF3, and PROX143,44 were highly enriched in cluster 3
(Supplementary Fig. 10c, d). Interestingly, the expanded cluster
5 seemed to have an enrichment in Tert and Dll4, suggesting that
this cluster may represent the quiescent-like progenitor pool
known as +445 (Fig. 8e, Supplementary Fig. 10c, d).
In summary, our results show the clearance of specific
regressors’ subclones expressing IFN related signaling and Notch
activation, as well as the expansion of subclones that express
IL10 suppressive pathway with expansion of Wnt and secretory-
like “states” (cluster 3), as well as a putative “quiescent”-like
progenitor state (cluster 5) (Fig. 8e).
Discussion
In the present study, we take advantage of the fast zebrafish larvae
xenograft model to study the crosstalk between human cancer
cells and the innate immune system. Previous work15 suggested
that although most human tumors engraft well, some are cleared
from the zebrafish host. Here, we studied a pair of human CRC
cells derived from the same patient at different stages of tumor
progression—SW480 from the primary tumor, and SW620 from
a lymph node metastasis isolated 6 months later. While
SW480_regressors engraft poorly and are mostly cleared in
4 days, SW620_progressors have high engraftment rates. Gene
expression assessed by RNA-seq of these tumors revealed the
involvement of innate immune-related pathways that may con-
tribute to this phenotype. Indeed, we found that SW480 cells
recruit neutrophils and macrophages more efficiently than
SW620. However, SW620 can polarize macrophages toward a
M2-like pro-tumoral phenotype. Genetic and chemical depletion
of myeloid cells demonstrate that macrophages and neutrophils
play a crucial role in tumor clearance. We also performed re-
transplantation experiments of in vivo selected tumors and
Fig. 7 Innate immunoediting in zebrafish xenografts. a Schematic illustration of SW480 escaper cells selection from SW480 parental xenografted (see
“Methods” for more info). b Representative confocal images of tumoral masses of SW480 parental and SW480zEscapers xenografts at 4 dpi.
c Quantification of engraftment at 4 dpi (Fisher exact test ****P < 0.0001). Error bars represent mean ± S.D. Each dot represents one independent
experiment. d Quantification of tumor size—no. of tumor cells, at 4 dpi (unpaired two-sided Mann–Whitney test ****P < 0.0001). e Quantification of
mitotic tumor cells at 4 dpi (unpaired two-sided Mann–Whitney test ns= 0.25). f Quantification of apoptotic tumor cells at 4 dpi (unpaired two-sided
Mann–Whitney test *P= 0.01). g Quantification of macrophage present in the TME of SW480 parental versus SW480Zesc at 4 dpi (unpaired two-sided
Mann–Whitney test ****P < 0.0001). In dot plots, error bars represent mean ± SEM. Scale bars: 50 μm. Dashed lines encircle tumor areas. Nuclei are
stained with DAPI. N is depicted in the chart. Each dot represents one xenograft. Data of SW480zEscapers results from three independent injections.
Source data are provided as a Source data file.
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showed that these tumors engrafted more efficiently and gener-
ated bigger tumors with reduced macrophage infiltrates. These
results suggest that zebrafish innate immunity can immune-shape
tumors toward tumorigenesis.
Finally, single-cell transcriptome analysis clearly shows a fast
tumor selection process, with clearance and expansion of specific
subclones or “cell states” in just 3 days. In accordance with our
hypothesis, the “cleared”-regressor subclones were associated
with activation of immune-inflammatory pathways and escaper-
expanded subclones with an enrichment of IL10 immune sup-
pressor pathway and a secretory-like fate. Interestingly, we
observed a clearance of subclones with active Notch signaling.
The role of Notch signaling and of the identified immune-related
pathways will be the subject of future investigation.
The concept of immunoediting has been mainly focused on
adaptive immunity46,47, and only one study, to our knowledge16,
has shown that innate immunity on its own is able to perform
immunoediting. O’Sullivan describes the role of NK cells in
educating macrophages toward an anti-tumoral state that act as
crucial effectors in immunoediting in a RAG2−/− x γc (−/−)
mouse model of induced sarcoma. In the present study, we show
that not only macrophages play an essential role but also that
neutrophils contribute to clearance and therefore to immunoe-
diting. We may speculate that, as NK cells educate macrophages
in the O’Sullivan model, neutrophils might also interact with
macrophages, possibly “re-educating” them toward an anti-
tumoral phenotype.
These results, which show that neutrophils and macrophages
may have an active anti-tumoral role, are in accordance with CRC
clinical data that suggest that TAMs and TANs are associated
with a favorable prognosis, especially in early stages48–52. On the
other hand, in other types of cancer such as lung, gastric, gyne-
cological, and breast cancer, high infiltration of TAMs correlates
with a poor clinical prognosis6,53.
Although the presence of macrophages might indicate a poor
prognosis, macrophages can be in an anti-tumoral state and
therefore tumoricidal, becoming instead a good prognosis. Or
on the other hand, if the tumor has been able to communicate
with the nearby macrophages and “talked them” into becoming
pro-tumoral and immunosuppressive then it will be indeed an
indicative of a bad prognosis. Thus, identifying the functional
state of the TME cells becomes fundamental to anticipate prog-
nosis and also response to immunotherapy, i.e., defining a hot
(permissive) or cold (immunosuppressed) TME. Many different
markers have emerged to classify immune cell types as pro- or
anti-tumoral. However, no universal robust marker which may
help guide treatment decisions, has been found so far. Most
studies use a battery of different molecules to identify the mac-
rophage subtypes52–57, although this battery also varies between
studies. This is probably due to the amazing plasticity and
diversity of the different macrophage populations. There are not
two static states but multiple states that are dynamic and inter-
changeable58–60. Also, there are numerous types of macrophages
with different embryonic origins, leading to a huge heterogeneity
Fig. 8 Single-cell transcriptome profiling reveals the clearance and expansion of different SW480 subclones. a Schematic illustration of the design of
the experiment. SW480 cells were injected into 2 dpf zebrafish embryos, and at 1 and 4 dpi, tumors were dissected and processed for scRNAseq. b Relative
frequencies of the cell clusters present in each library replicate. c Uniform Manifold Approximation and Projection (UMAP), representing the relative
similarity between individual cells, colored by cell cluster and divided by timepoints 1 and 4 dpi. d Heatmap representation of normalized enrichment scores
(NES) of representative pathways with statistically significant (adjusted P-value < 0.05) enrichment in gene set enrichment analysis (GSEA), comparing
the gene expression of each cellular subgroup to all the others. Red colors mean that genes in that pathway tend to be more expressed in that cellular
subcluster, while blue means that genes tend to be less expressed. Significant NES values are marked with asterisk (Fisher exact test *: adjusted P-value
< 0.05; **: adjusted P-value < 0.01; ***: adjusted P-value < 0.001). Gray colors are cases where a NES value could not be obtained and should be considered
non-significant (see Supplementary Data 2 for GSE values). e Schematic illustration of expansion/reduction of each cluster from 1 to 4 dpi with the most
representative pathways and genes.
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of phenotypes and functions. Consequently, to find a good and
universal marker of the innate functional status has been a major
hurdle, that has not been yet achieved59.
Numerous studies have shown that the zebrafish model can
respond to human tumor angiogenic cues and therefore be used
as a reporter of the angiogenic potential of tumor cells61,62. Here,
we show that zebrafish can also “read” the innate immune cues
and reconstitute an innate microenvironment in just 4 days. We
propose that by analyzing the engraftment/clearance in wild-type
(wt) and mutants as well as using reporters, such as TNFa, it is
possible to infer the function of these innate immune cells.
Our results are opening the possibility of using the zebrafish
Avatar model as a living biomarker to infer the innate TME state,
i.e., reveal an anti-tumoral state (immune permissive/hot) or pro-
tumoral (and immune suppressive/cold). Importantly, this could
have a prognostic value and possibly help select patients that can
benefit from TME-based therapies, such as immunotherapy. In
addition, we also propose that future experiments can use zeb-
rafish xenografts to study innate immune suppressive mechan-
isms and possibly find new therapeutics to enhance
immunotherapy.
Methods
Zebrafish welfare and handling. Zebrafish (Danio rerio) model was handled and
maintained according to the standard protocols of the European Animal Welfare
Legislation, Directive 2010/63/EU (European Commission, 2016) and Champali-
maud Fish Platform. All protocols were approved by the Champalimaud Animal
Ethical Committee and Portuguese institutional organizations—ORBEA (Órgão de
Bem-Estar e Ética Animal/Animal Welfare and Ethics Body) and DGAV (Direção
Geral de Alimentação e Veterinária/Directorate General for Food and Veterinary).
Zebrafish transgenic and mutant lines. According to the purpose of each
experiment, different genetically modified zebrafish lines were used in this study:
Tg(mpx:eGFP)23, Tg(mpeg1:mCherry-F)24, Tg(mpeg1:mCherry-F; tnfa:GFP-F)24,
runx1w84x mutant26, and csf1raj4blue (panther) mutant27. Wild-type Tubingen
strain or Casper mutants were used as control and as a background line for the
experiments.
Human tissue processing. Human samples used for zebrafish patient-derived
xenograft (zAvatars) establishment were obtained from Champalimaud Hospital
and Prof Fernando Fonseca Hospital with written informed consent. The study was
approved by both Hospital Ethics Committees.
Neoplastic colorectal tissues were obtained from surgically resected specimens.
Human tissue processing protocol was performed as previously described15. In
brief, samples were washed in ice-cold 1X-PBS, chopped into small pieces, and
cryopreserved in 90% FBS 10% DMSO. Cryopreserved human primary tumor
tissue was defrosted, further washed, and minced in mix1 (DMEM-F12 (Gibco),
60%FBS (Sigma), Y-27632 10 μM (Cliniscience), Primocin 100 μg/ml (Invivogen),
Putrescin 10 μg/ml (Sigma-Aldrich), Nicotinamide 10 mM (Sigma-Aldrich), and
digested with Liberase (Roche) for 5–10 min at 37 °C. Tumor cell suspension was
passed through a 70 μm cell strainer and centrifuged at 250 × g for 4 min at 4 °C.
For cell labeling, tumor cells were incubated with CM-DiI (1:100) in mix1 but
without FBS and supplemented with DNase I 5 U/ml (Fermentas), for 15 min at
37 °C. Cells were resuspended in mix1 supplemented with human EGF (50 ng·mL−1,
Peprotech) at final concentration of ~0.25 × 106 cells per milliliter.
Human cancer cell lines and culture. Human breast cancer cell lines Hs578T,
MDA-MB-231, and MDA-MB-468 were kindly provided by Mónica Bettencourt
Dias’ Lab (Instituto Gulbenkian da Cien̂cia).
Human colorectal cancer cell lines SW480, SW620, and HT29 were purchased
from American Type Culture Collection (ATCC), whereas HCT116 and Hke3
isogenic cell lines were kindly provided by Ângela Relógio (Charité Medical
University of Berlin). SW48 cell line was provided by Luis Costa Lab (ATCC,
Instituto de Medicina Molecular). All cell lines were kept and grown in Dulbecco’s
modified Eagle medium (DMEM) High Glucose (Biowest) and supplemented with
10% fetal bovine serum (FBS) (Sigma-Aldrich) and antibiotics (100 Uml−1
penicillin and 100 μg ml−1 streptomycin, Hyclone) in a humidified 5% CO2
atmosphere at 37 °C. All cell lines were authenticated through short tandem repeat
(STR) profile analysis and tested routinely for mycoplasma contamination.
Cell staining. Tumor cells were grown to 70% confluence, washed with Dulbecco’s
phosphate-buffered saline (DPBS) 1X (Biowest) and stained in a flask with lipo-
philic dyes—Vybrant CM-DiI (4 μl/ml in DPBS 1X), green CMFDA (1 μl/ml in
DPBS 1X, 1 mM stock), or Deep Red Cell Tracker (1 μl/ml in DPBS 1X, 10 mM
stock) (Life Technologies), for 10 min at 37 °C, in darkness. Cells were washed with
DPBS and detached with 2 mM EDTA by scrapping. Cell suspension was collected
to 1.5 ml eppendorfs, centrifuged at 250 × g, for 4 min at 4 °C, and resuspended in
DMEM. Cell viability was assessed by trypan blue exclusion method, and cell
number was determined by hemocytometer counting. Cells were resuspended in
DPBS 1X to a final concentration of 0.25 × 106 cells/μl.
Zebrafish xenografts. Fluorescently labeled cancer cells were injected using
borosilicate glass microcapillaries under a fluorescence scope (Zeiss Axio Zoom.
V16) with a mechanical micropipetor attached (World Precision Instruments,
Pneumatic Pico pump PV820). Approximately 500–1000 cells were injected into
the periviteline space (PVS) of 2 dpf zebrafish embryo, previously anesthetized with
Tricaine 1X (Sigma-Aldrich). After injection, zebrafish xenografts remained for
~10 min in Tricaine 1X and then transferred to E3 medium and kept at 34 °C. At 1
dpi, zebrafish xenografts were screened according to the presence or absence of
tumoral mass. Xenografts with cells in the yolk sac or cellular debris were dis-
carded, whereas successfully ones were grouped according to their tumor size,
which was classified by comparison with eye’s size. Every day xenografts were
checked—dead ones removed and E3 medium refreshed. Four days after injection
the engraftment rate was calculated (formula below) and zebrafish xenografts were
sacrificed, fixed with 4% (v/v) Formaldehyde (FA) (Thermo Scientific) at 4 °C
overnight and preserved at −20 °C in 100% (v/v) methanol.
Xenograft engraftment calculation
Engraftment ð%Þ ¼ no: of xenografts with tumor at 4 dpi
total no: of xenografts at 4 dpi
´ 100
Ratios of SW480 and SW620. SW480 and SW620, prepared for injection as
mentioned above, were mixed in different proportions right before injection to
generate the following ratios:
Mix 3:1—75% SW480+ 25% SW620
Mix 1:1—50% SW480+ 50% SW620
Mix 1:3—25% SW480+ 75% SW620
Chemo/radio treatment of zebrafish xenografts and zAvatars. At 1 dpi, zeb-
rafish xenografts with the same tumor size were randomly distributed in the
treatment groups: control E3 medium and FOLFOX in E3 (4.2 mM 5-FU, 0.18 mM
folinic acid, 0.08 mM oxaliplatin) for three consecutive days, replaced daily.
Maximum tolerated concentration in zebrafish larvae was determined as previously
described15. Single dose of 25 Gy was delivered to zAvatars at 1 dpi as described in
ref. 63 and 3 days after the experiment ended. In brief, Irradiation procedures and
regimens were adapted for zebrafish xenografts by the Champalimaud Foundation
Radiation Oncology Department. The 6MV X-rays beams with 25 Gy were cal-
culated with the same algorithm used in clinical practice (ECLIPSE, Varian Medical
System, CA) and was delivered via a linear accelerator (Truebeam, Varian Medical
Systems, CA). Irradiation was targeted to the center of a defined area of 30 × 30 cm
from a 6-well plate with the anesthetized zebrafish (6 mL of E3 medium per well,
~12 xenografts per well). The well plates were positioned with a source-to-surface
distance of 100 cm.
Zebrafish macrophage ablation with clodronate liposomes. For the selective
depletion of macrophages, Liposomes-encapsulated PBS (L-PBS) and Liposomes-
encapsulated clodronate (L-Clodronate) were purchased from Liposoma. At the
time of cell resuspension immediately prior to cell microinjection into zebrafish,
cells were resuspended either in PBS, L-PBS, or L-Clodronate at a final con-
centration of 0.25 × 106 cells/μL.
Imaging and analysis of zebrafish xenografts. All images were obtained using a
Zeiss LSM 710 fluorescence confocal microscope, generally with a 5 μm interval in
a total of ~60 μm stack using the z-stack function. Generated images were pro-
cessed using the FIJI/ImageJ software. Some of the acquired z-stacks were projected
using maximum intensity projection. Number of cells was quantified with ImageJ
software Cell counter plugin.
To assess tumor size, three representative slices of the tumor, from the top
(Zfirst), middle (Zmidle), and bottom (Zlast), per z-stack per xenograft were
analyzed and a proxy of total cell number of the entire tumor (DAPI nuclei) was
estimated as follows:
tumor size ¼ no: of DAPI cells Zfirstþ no: of DAPI cells Zmidleþ no: of DAPI cells Zlast
total number of slices ´ 1:5
The 1.5 correction number was estimated to these CRC cells that have a nuclei
with an average of 10–12 μm of diameter. Number of mitotic figures, activated
caspase-3, macrophages, neutrophils, M1 and M2-like TNFa+ and TNFa−
macrophages, as well as other inflammatory cells were counted in every slice,
starting in the first and finishing in the last slice of the tumor. To get the percentage
of each, raw number was divided by tumor size.
Bulk RNA-seq sample preparation. SW480 and SW620 tumors were dissected
from zebrafish xenografts at 2 dpi. A pool of ~30 tumors from each type of tumor
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and independent experiments was collected in RNAlater solution (#AM7020,
Ambion) and kept at −20 °C until RNA extraction. The engraftment rate (deter-
mined at 4 dpi with remaining zebrafish xenografts) of SW480 and SW620 used for
gene expression analysis was the following: SW480_B—8%, SW480_A—30%, and
SW480_7—31.5%; SW620_1—92.4%, SW620_2—92%, SW620_5—97.2%, and
SW620_7—98.3%. To study the genetic signatures of the underlying observed
phenotypes (regressors and progressors), total RNA was extracted from the dis-
sected tumors using Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA,
USA) and further purified with RNeasy Plus Micro Kit (Qiagen), in accordance
with the manufacturer’s instructions.
RNA-seq analysis. mRNA-libraries were prepared using the Smart-seq2 protocol
(Illumina, USA). Samples were sequenced by Next-Seq 500 Illumina sequencer and
unstranded single-end mRNA-seq libraries of 76 bp were obtained. An average of
~38 million reads per sample. These RNA-seq libraries contain a mixture of human
and zebrafish RNA derived from the xenograft as well as the host cells infiltrating
it. After quality control assessment with FastQC64 (v0.11.7) and low quality reads
filtering with Trimmomatic65 (v0.38), all sequenced libraries were quantified with
Salmon66 (v0.13.1 using the respective transcript human annotations (Hg38) from
the Ensembl genome database project). For downstream analysis package Txim-
port67 was used, to import transcript lengths and abundance estimates and export
(estimated) count matrices. And differential expression analysis was performed
using Limma68. Genes with a FDR < 0.05 and absolute log2 foldchange >1 were
considered significant.
Pathway enrichment analysis of a ranked gene list using GSEA. Pathway
enrichment analysis helps us gain biological insight into large gene lists typically
resulting from high throughput experiments. It identifies biological pathways that
are enriched in the gene list more than expected by chance. A ranked gene list
obtained from SW480 low engraftment versus SW620 high engraftment differential
expression analysis was input to GSEA PreRank19 (v4.0.2, Broad Institute, Cam-
bridge, MA) as RNK file. We used curated gene sets from Molecular Signatures
Database69 (v7.0, Hallmarks and Canonical Pathways including KEGG and
REACTOME). We then ran GSEA PreRank using the default weighted statistic. The
thresholds for significance were determined by permutation analysis (1000 permu-
tations), selecting the enriched pathways with a false discovery rate (FDR) < 0.07.
Single-cell RNA-seq preparation. SW480 tumors were dissected from zebrafish
xenografts at 1 and 4 dpi. A pool of ~100 tumors was collected to 1 ml of DMEM
High Glucose (Biowest), 10 µM of Anoikis inhibitor Y-27632 2HCl (#S1049,
Selleckchem) and 5U of Dnase (#EN0521, Thermofisher). Tumors were then
digested by adding 5 µl of liberase (5 mg/ml, #05401020001, Roche), for 2–3′ at 37 °
C and centrifuged at 300 × g, for 4′ at 4 °C. Cell suspension was resuspended in
DPBS 1X (Biowest), EDTA 2mM (Sigma), FBS 2% (Sigma) and Hepes (Fisher
Scientific) 25 mM, filtered with 70 µm strainer, and DAPI (5 µg/ml) was added as a
control for live-cell selection in FACS (stained DAPI cells were dead and DAPI
negative_live were sorted). Cells were kept on ice and FACS sorted into 384-well
plates containing 384 primers and Mineral oil (Sigma).
Single-cell RNA-seq analysis. During sequencing, Read 1 was assigned 26 base
pairs and was used for identification of the Illumina library barcode, cell barcode
and Unique Molecular Identifiers (UMI). R2 was assigned 60 base pairs and used to
map the Human reference transcriptome with BWA70. Unique barcode gene
counts were used for further processing in Seurat36. Only genes present in at least
10 cells were considered. Moreover, we only considered barcodes with counts in
more than 2000 genes and with <25% of counts in mitochondrial genes. After
quality control and filtering, we were left with a total of 533 human GFP positive
cells from the first timepoint and 293 human GFP positive cells from the second.
After normalization, the 2000 most variable genes were used for dimensionality
reduction and clustering. We chose clustering parameters empirically to provide a
balance between the number of clusters and their size. We then ran GSEA analysis
for each cluster by ranking genes according to their differences in gene expression
to the other clusters. Cells were displayed in a 2-dimensional plot using uniform
manifold approximation and projection (UMAP)37. Normalized expression values
of genes from selected enriched pathways were also displayed as violin plots or
heatmaps. The Normalized expression values of genes used for visualization cor-
respond to the log2 of total cell counts divided by 10,000 (very similar to the
traditional CPM). For heatmaps, expression values were displayed scaled by gene
(row z-score).
Mouse welfare and strains. Mice experiments and corresponding protocols were
approved by the Champalimaud Animal Ethical Committee and portuguese
institutional organizations—ORBEA (Órgão de Bem-Estar e Ética Animal/Animal
Welfare and Ethics Body) and DGAV (Direção Geral de Alimentação e Veter-
inária/Directorate General for Food and Veterinary).
Rag1−/− C57BL/6J mice were bred at 23 °C, with 40–60% relative humidity,
12 h light cycle (8 am–8 pm) by the animal facility of Champalimaud Vivarium,
Lisbon, Portugal.
SW480 and SW620 transduction by lentiviral infection. To facilitate posterior
quantification of each population on mice experiments, we first generated SW480
and SW620 cell expressing GFP and tomato fluorescent proteins, respectively (false
colors in the figures).
SW480 and SW620 cells were seeded (1 × 106 cells per well) in 6-well plates and
incubated at 37 °C ON. In the following day, a range of dilutions (1:50 up to
1:1000) of lentivirus vectors were added to each well. DMEM supplemented with
10%FBS, 1%P/S, and 8 μg/mL polybrene was used to enhance transduction
efficiency. Twenty-four hours later, medium was replaced to obtain stable
transduced cells and maintained at 37 °C. Untransduced cells with the same
antibiotics were used as controls.
Cells were expanded and the transduction efficiency was measured by flow
cytometry (BD LSRFortessa™ X-20 cell analyser—Biosciences). Cells were then
sorted (BD FACSAria Fusion) using FACS Diva software v8, with a 99% of purity.
Mouse SW480 xenografts and macrophage ablation. Approximately, 1 × 106
SW480 cells were resuspended with 1:1 matrigel (reduced growth factors, Corning)
and one of the following conditions: PBS, L-PBS, or L-Clodronate. SW480 were
injected subcutaneously in the right flank of 8-week-old Rag1−/− C57BL/6J mice
(N= 5 per group).
For macrophage depletion, L-Clodronate was administrated right upon tumor
cell inoculation through intravenous injection (retro-orbital injection). The same
protocol was performed for PBS or L-PBS controls. To avoid macrophage
repopulation, the same treatment conditions were injected every 4 days. Tumor
size was measured once a week using caliper measurements and tumor volumes
were calculated according to a standard formula:
4
3
π ´ ðShort axis of the tumor=2Þ2 ´ ðLong axis of the tumor=2Þ
At the end of the experiment, mice were euthanized with carbon dioxide, and
tumor size was measured and immediately fixed in 4% FA.
Mouse SW480, SW620, or MIX 1:1 xenografts. Approximately, 1 × 106 tumor
cells (SW480, SW620, or MIX 1:1) were resuspended with 1:1 matrigel (reduced
growth factors, Corning) and subcutaneously injected in the right flank of 7–10-
week-old Rag1−/− C57BL/6J mice.
Tumor size was measured every 3–4 days using caliper measurements and
tumor volumes were calculated according to a standard formula of:
4
3
π ´ ðShort axis of the tumor=2Þ2 ´ ðLong axis of the tumor=2Þ
At the end of the experiment, mice were euthanized with carbon dioxide and
tumor size was measured and immediately fixed in 4% (v/v) FA.
Mouse xenografts tumor isolation and staining. Tumor-bearing mice were
euthanized according to approved guidelines with carbon dioxide three
weeks (~24 days) after inoculation of cancer cells. Subcutaneous tumors were
resected and measured with a caliper. Tumors were thoroughly minced with
scalpels, transferred to 1.5 mL Eppendorf tubes, and digested in 1 ml of PBS 1X
containing 10 μl of Liberase TM (5 mg/ml) (Sigma) and 3 μl of DNAse I (Thermo
Scientific) for 30 min at 37 °C. Digested suspension was filtered through a 40 μm
mesh into a 15 mL Falcon tube. Digestion was then blocked by addition of buffer
containing 800 ml of HBSS (Corning), 2 ml of EDTA 0.5 M, and 0.1 g of BSA.
Tubes were centrifuged 10 min at 300 × g. Pellet was resuspended in FACS buffer
(PBS 1 × wo Ca/Mg, EDTA 2mM, and FBS 2%). Total viable cell yield per volume
was determined using Trypan Blue and an automated cell counter. Tumor single-
cell suspension was then stained for FACS analysis.
Flow cytometry antibodies. The following monoclonal antibodies were used for
flow cytometric analysis of tumors: Live/dead discrimination (LIVE/DEAD® Fix-
able Aqua Dead Cell Stain Kit, 1:500, Thermo Scientific, #L34957), anti-human
EpCAM CD326 (9C4, Biolegend, 5:100), APC/Cyanine7 anti-mouse CD45.2 (104,
Biolegend, 1:200), anti-mouse F4/80 PE-Cyanine7 (BM8, eBioscience, 1:200), FITC
anti-mouse CD80 (16-10A1, Biolegend, 1:200).
Flow cytometry gating strategy for mouse xenografts. Data were acquired
using the BD LSRFortessa™ X-20 cell analyzer (Biosciences) and analyzed using
FlowJo™ v10.6.1 software. Populations were determined as follows: Human cells
(LIVE/DEAD−EpCAM+), SW620 cells (LIVE/DEAD−EpCAM+PE+FITC−),
SW480 cells (LIVE/DEAD−EpCAM+PE−FITC+), mouse cells (LIVE/DEAD−
EpCAM−), Macrophages (LIVE/DEAD−EpCAM–CD45+F4/80+), anti-tumoral
M1-like macrophages (LIVE/DEAD−EpCAM−CD45+F4/80+CD80+).
See Supplementary Fig. 7.
Generation of SW480zEscapers. Parental SW480 cells expressing GFP (red false
color in Fig. 7) were injected into the PVS of 2 dpf zebrafish embryos. At 1 dpi,
zebrafish xenografts were scored according to the tumor size and kept in E3
medium at 34 °C until day 4. Tumors that persisted until 4 dpi were dissected and
expanded in vitro for three passages in multi-well plates—which we named
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SW480zEscapers. SW480zEscapers were injected in new zebrafish embryos with 2
dpf and engraftment rate was quantified at 4 dpi.
Immunofluorescence. Whole-mount immunofluorescence was performed starting
hydration through methanol series (75% > 50% > 25%). Next, xenografts were
permeabilized with 0.1% (w/v) Triton in PBS and blocked with a mixture of PBS
1X, BSA, DMSO, Triton 1% (w/v), and goat serum, for 1 h at room temperature.
The xenografts were then incubated with primary antibody Anti-Cleaved caspase-3
(Asp175) (rabbit, Cell Signaling, 1:100, #9661) or Mpx (rabbit, GeneTex, 1:50,
#gtx128379) overnight and followed by incubation of the secondary antibody goat
anti-rabbit IgG (H+L) 650 (Dylight, 1:400, #84546) and 50 μg/ml DAPI (for
nuclear counterstaining), again overnight.
Wash and fixation steps were performed, and xenografts mounted between two
coverslips, allowing double side acquisition using Mowiol mounting media (Sigma).
Statistical analysis. Statistical analysis was performed using GraphPad Prism
8.0 software. All data sets were challenged by D’Agostino & Pearson and
Shapiro–Wilk normality tests. In general, data sets with a Gaussian distribution
were analyzed by parametric unpaired t test and data sets that did not pass the
normality tests were analyzed by nonparametric unpaired Mann–Whitney test. All
were two-sided tests with a confidence interval of 95%. The exception was related
to Fig. 4 where data were analyzed by paired tests either by a parametric paired t
test (in Fig. 4g) or by paired nonparametric Wilcoxon test (Fig. 4h). Differences
were considered significant at P < 0.05 and statistical output was represented as
follows: non-significant (ns) ≥0.05, *<0.05, **<0.01, ***<0.001, ****<0.0001. The
graphs indicate the results as AVG ± standard error of the mean (SEM) or standard
deviation (SD). In addition, for small number of samples (<10), we performed an
effect size analysis—Cohen’s D with a Hedges’ g correction (g), using Cohen’s D
1988 scale (g): g > 0.2 low; g > 0.5 moderate; g > 0.8 high.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data from the bulk and single-cell RNA-seq analyses have been deposited in NCBI Gene
Expression Omnibus (GEO) with the accession number GSE163751. Source data from
Figs. 1–7, and Supplementary Figure 7 are provided as a Source data file. The remaining
data are available within the Article, Supplementary Information, or available from the
authors upon request. Source data are provided with this paper.
Code availability
The code to reproduce results from bulk and single-cell RNA-seq is available at
Supplementary Software 1.
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